Scholar Rock Holding Corp
NASDAQ:SRRK 3:59:58 PM EDT
| Market Cap (Intraday) | 1.07B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $36.35 |
| 50-Day MA | $36.25 |
| 200-Day MA | $41.08 |
Scholar Rock Holding Corp Stock, NASDAQ:SRRK
301 Binney Street, 3rd floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.259.3860
Number of Employees: 119
Description
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.